• LG CNS expanded its manufacturing AI transformation push into pharmaceuticals with a new smart-factory showcase at CPHI Milan 2026.
• Focus shifted toward end-to-end deployment across factory design, production operations, and quality management for pharma and biotech plants.
• Strategy targets new builds or capacity expansions, positioning the group as a turnkey provider for pharma manufacturing automation.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. LG CNS Co. Ltd. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202610070201PR_NEWS_EURO_ND__EN63522) on October 07, 2026, and is solely responsible for the information contained therein.